Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Maves vs Southern Vitality and Weight Loss

Maves
Graded #89

Higher grade

vs+6.599999999999994
Southern Vitality and Weight Loss
Graded #227

Lower grade

The verdict

Maves takes it — 71.8/100 to 65.2/100.

Maves grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging, with…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaves +30
84
54
Dose & formulationMaves +1
65
64
Clinical oversightSouthern Vitality and Weight Loss +11
76
87
Labs & monitoringSouthern Vitality and Weight Loss +2
52
54
FulfillmentMaves +16
87
71
Contract termsSouthern Vitality and Weight Loss +6
55
61
Maves · left barSouthern Vitality and Weight Loss · right bar

The numbers

MetricMavesSouthern Vitality and Weight Loss
WeighScore71.8/10065.2/100
GradeCC
Scorecard rank#89#227
Semaglutide$99/mo (starting dose, first-month rate, compounded)$199/mo (compounded)
TirzepatideNot disclosed$299/mo (compounded)
CoverageAll 50 states1 state
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Maves

Graded #89 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed

Strengths

  • Compounded GLP-1 (semaglutide and tirzepatide) starting as low as $99/mo
  • Names its compounding pharmacy partners (PerfectRx, The Pharmacy Hub, RX Compound Store) — uncommon transparency
  • Free telehealth consult and free shipping; no membership or hidden fees
  • Bi-weekly check-ins; operating since 2012
  • Flexible monthly financing available at checkout

Where it loses points

  • This is one physical clinic in Valdosta, Georgia, not a national telehealth service — nothing here is available to a reader outside Georgia
  • The advertised 'as low as $99/month' is a semaglutide three-month starter pack ($299 paid up front), not a tirzepatide rate and not a monthly one
  • Month-to-month rates are $199 semaglutide and $299 tirzepatide
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard